TargetMol

Estredox

Product Code:
 
TAR-T27287
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T27287-5mg5mg£650.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27287-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Estredox, an estrogen receptor agonist, is used potentially for the treatment of vasomotor symptoms.
CAS:
103562-82-9
Formula:
C25H31NO3
Molecular Weight:
393.527
Purity:
0.98
SMILES:
[H][C@@]12CCC(OC(=O)C3=CN(C)C=CC3)[C@@]1(C)CC[C@]1([H])c3ccc(O)cc3CC[C@@]21[H]

Documents

References

1. Prokai-Tatrai K, Szarka S, Nguyen V, Sahyouni F, Walker C, White S, Talamantes T, Prokai L. "All in the mind"? Brain-targeting chemical delivery system of 17?-estradiol (Estredox) produces significant uterotrophic side effect. Pharm Anal Acta. 2012;Suppl 7. doi: 10.4172/2153-2435.S7-002. PubMed PMID: 24380028; PubMed Central PMCID: PMC3874273. 2. Patthy M, Seres G, T?th-Sarudy E, Hazai I, Pallagi I, Simay A, Bodor N. Determination of estredox, a compound with sustained estradiol function, and its impurity profile by HPLC. Pharmazie. 2008 Mar;63(3):210-6. PubMed PMID: 18444509. 3. Szir?ki I, Horv?th K, Bodor N. Comparative evaluation of Estredox, a brain-targeted estradiol delivery system versus traditional estrogen replacement therapy. Pharmazie. 2006 Feb;61(2):140-3. PubMed PMID: 16526562. 4. Tapfer MK, Sebestyen L, Kurucz I, Horvath K, Szelenyi I, Bodor N. New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox. Pharmacol Biochem Behav. 2004 Mar;77(3):423-9. PubMed PMID: 15006452.